Nathan Dwarshuis
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Nathan Dwarshuis has a total of 76 co-authors. Here are the top co-authors by number of shared publications:
- Justin M. Zook
Material Measurement Laboratory, National Institute of Standards and Technology, Gaithersburg, USA
4 shared publications Justin Wagner
Material Measurement Laboratory, National Institute of Standards and Technology, Gaithersburg, MD, USA
4 shared publications- Fritz Joachim Sedlazeck
Baylor College of Medicine
3 shared publications - Nathanael D. Olson
National Institute of Standards and Technology, Material Measurement Laboratory, 100 Bureau Dr., Gaithersburg, MD 20899, USA
3 shared publications Peter Tonner
Material Measurement Laboratory, National Institute of Standards and Technology, Gaithersburg, USA
2 shared publications- Adam C. English
Human Genome Sequencing Center, Baylor College of Medicine, Houston, TX, USA
1 shared publication
Latest Publications
- Open Access
A complete diploid human genome benchmark for personalized genomics
Human genome resequencing typically involves mapping reads to a reference genome to call variants; however, this approach suffers from both technical and reference biases, leaving many duplicated and structurally polymorphic regions of the genome unmapped. Consequently, existing variant benchmarks, generated by the same methods, fail to assess these complex regions. To address this limitation, we present a telomere-to-telomere genome benchmark that achieves near-perfect accuracy (i.e. no detectable errors) across 99.4% of the complete, diploid HG002 genome. This benchmark adds 701.4 Mb of autosomal sequence and both sex chromosomes (216.8 Mb), totaling 15.3% of the genome that was absent from prior benchmarks. We also provide a diploid annotation of genes, transposable elements, segmental duplications, and satellite repeats, including 39,144 protein-coding genes across both haplotypes. To facilitate application of the benchmark, we developed tools for measuring the accuracy of sequencing reads, phased variant call sets, and genome assemblies against a diploid reference. Genome-wide analyses show that state-of-the-art de novo assembly methods resolve 2–7% more sequence and outperform variant calling accuracy by an order of magnitude, yielding just one error per 100 kb across 99.9% of the benchmark regions. Adoption of genome-based benchmarking is expected to accelerate the development of cost-effective methods for complete genome sequencing, expanding the reach of genomic medicine to the entire genome and enabling a new era of personalized genomics.
Open AccessA complete diploid human genome benchmark for personalized genomics
Human genome resequencing typically involves mapping reads to a reference genome to call variants; however, this approach suffers from both technical and reference biases, leaving many duplicated and structurally polymorphic regions of the genome unmapped. Consequently, existing variant benchmarks, generated by the same methods, fail to assess these complex regions. To address this limitation, we present a telomere-to-telomere genome benchmark that achieves near-perfect accuracy (i.e. no detectable errors) across 99.4% of the complete, diploid HG002 genome. This benchmark adds 701.4 Mb of autosomal sequence and both sex chromosomes (216.8 Mb), totaling 15.3% of the genome that was absent from prior benchmarks. We also provide a diploid annotation of genes, transposable elements, segmental duplications, and satellite repeats, including 39,144 protein-coding genes across both haplotypes. To facilitate application of the benchmark, we developed tools for measuring the accuracy of sequencing reads, phased variant call sets, and genome assemblies against a diploid reference. Genome-wide analyses show that state-of-the-art de novo assembly methods resolve 2–7% more sequence and outperform variant calling accuracy by an order of magnitude, yielding just one error per 100 kb across 99.9% of the benchmark regions. Adoption of genome-based benchmarking is expected to accelerate the development of cost-effective methods for complete genome sequencing, expanding the reach of genomic medicine to the entire genome and enabling a new era of personalized genomics.
- Top Cited PapersOpen Access
- 19 October 2024
- Published by Springer Nature in Nature Communications
- Vol. 15 (1) , 1-13
The GIAB genomic stratifications resource for human reference genomes
Despite the growing variety of sequencing and variant-calling tools, no workflow performs equally well across the entire human genome. Understanding context-dependent performance is critical for enabling researchers, clinicians, and developers to make informed tradeoffs when selecting sequencing hardware and software. Here we describe a set of “stratifications,” which are BED files that define distinct contexts throughout the genome. We define these for GRCh37/38 as well as the new T2T-CHM13 reference, adding many new hard-to-sequence regions which are critical for understanding performance as the field progresses. Specifically, we highlight the increase in hard-to-map and GC-rich stratifications in CHM13 relative to the previous references. We then compare the benchmarking performance with each reference and show the performance penalty brought about by these additional difficult regions in CHM13. Additionally, we demonstrate how the stratifications can track context-specific improvements over different platform iterations, using Oxford Nanopore Technologies as an example. The means to generate these stratifications are available as a snakemake pipeline at https://github.com/usnistgov/giab-stratifications. We anticipate this being useful in enabling precise risk-reward calculations when building sequencing pipelines for any of the commonly-used reference genomes.
- 19 October 2024
- Published by Springer Nature in Nature Communications
- Vol. 15 (1) , 1-13
Top Cited PapersOpen AccessThe GIAB genomic stratifications resource for human reference genomes
Despite the growing variety of sequencing and variant-calling tools, no workflow performs equally well across the entire human genome. Understanding context-dependent performance is critical for enabling researchers, clinicians, and developers to make informed tradeoffs when selecting sequencing hardware and software. Here we describe a set of “stratifications,” which are BED files that define distinct contexts throughout the genome. We define these for GRCh37/38 as well as the new T2T-CHM13 reference, adding many new hard-to-sequence regions which are critical for understanding performance as the field progresses. Specifically, we highlight the increase in hard-to-map and GC-rich stratifications in CHM13 relative to the previous references. We then compare the benchmarking performance with each reference and show the performance penalty brought about by these additional difficult regions in CHM13. Additionally, we demonstrate how the stratifications can track context-specific improvements over different platform iterations, using Oxford Nanopore Technologies as an example. The means to generate these stratifications are available as a snakemake pipeline at https://github.com/usnistgov/giab-stratifications. We anticipate this being useful in enabling precise risk-reward calculations when building sequencing pipelines for any of the commonly-used reference genomes.
- Open Access
- 13 October 2024
- Published by Springer Nature in Communications Biology
- Vol. 7 (1) , 1-14
StratoMod: predicting sequencing and variant calling errors with interpretable machine learning
Despite the variety in sequencing platforms, mappers, and variant callers, no single pipeline is optimal across the entire human genome. Therefore, developers, clinicians, and researchers need to make tradeoffs when designing pipelines for their application. Currently, assessing such tradeoffs relies on intuition about how a certain pipeline will perform in a given genomic context. We present StratoMod, which addresses this problem using an interpretable machine-learning classifier to predict germline variant calling errors in a data-driven manner. We show StratoMod can precisely predict recall using Hifi or Illumina and leverage StratoMod’s interpretability to measure contributions from difficult-to-map and homopolymer regions for each respective outcome. Furthermore, we use Statomod to assess the effect of mismapping on predicted recall using linear vs. graph-based references, and identify the hard-to-map regions where graph-based methods excelled and by how much. For these we utilize our draft benchmark based on the Q100 HG002 assembly, which contains previously-inaccessible difficult regions. Furthermore, StratoMod presents a new method of predicting clinically relevant variants likely to be missed, which is an improvement over current pipelines which only filter variants likely to be false. We anticipate this being useful for performing precise risk-reward analyses when designing variant calling pipelines.
- 13 October 2024
- Published by Springer Nature in Communications Biology
- Vol. 7 (1) , 1-14
Open AccessStratoMod: predicting sequencing and variant calling errors with interpretable machine learning
Despite the variety in sequencing platforms, mappers, and variant callers, no single pipeline is optimal across the entire human genome. Therefore, developers, clinicians, and researchers need to make tradeoffs when designing pipelines for their application. Currently, assessing such tradeoffs relies on intuition about how a certain pipeline will perform in a given genomic context. We present StratoMod, which addresses this problem using an interpretable machine-learning classifier to predict germline variant calling errors in a data-driven manner. We show StratoMod can precisely predict recall using Hifi or Illumina and leverage StratoMod’s interpretability to measure contributions from difficult-to-map and homopolymer regions for each respective outcome. Furthermore, we use Statomod to assess the effect of mismapping on predicted recall using linear vs. graph-based references, and identify the hard-to-map regions where graph-based methods excelled and by how much. For these we utilize our draft benchmark based on the Q100 HG002 assembly, which contains previously-inaccessible difficult regions. Furthermore, StratoMod presents a new method of predicting clinically relevant variants likely to be missed, which is an improvement over current pipelines which only filter variants likely to be false. We anticipate this being useful for performing precise risk-reward analyses when designing variant calling pipelines.
- Open Access
StratoMod: Predicting sequencing and variant calling errors with interpretable machine learning
Despite the variety in sequencing platforms, mappers, and variant callers, no single pipeline is optimal across the entire human genome. Therefore, developers, clinicians, and researchers need to make tradeoffs when designing pipelines for their application. Currently, assessing such tradeoffs relies on intuition about how a certain pipeline will perform in a given genomic context. We present Stratomod, which addresses this problem using an interpretable machine-learning classifier to predict variant calling errors in a data-driven manner. We showed Stratomod can precisely quantify the likelihood of missing variants using Hifi or Illumina, and leveraged Stratomod’s interpretability to measure contributions from difficult-to-map and homopolymer regions for each respective outcome. Furthermore, we used Statomod to assess the likelihood of missing variants due to mismapping using linear vs. graph-based references, and identified the hard-to-map regions where graph-based methods excelled and by how much. For these we utilized our new benchmark based on the Q100 HG002 assembly, which contains previously-inaccessible difficult regions. Furthermore, Stratomod presents a new method of finding likely false negatives, which is an improvement over current pipelines which only filter false positives. We anticipate this being useful for performing precise risk-reward analyses when designing variant calling pipelines.
Open AccessStratoMod: Predicting sequencing and variant calling errors with interpretable machine learning
Despite the variety in sequencing platforms, mappers, and variant callers, no single pipeline is optimal across the entire human genome. Therefore, developers, clinicians, and researchers need to make tradeoffs when designing pipelines for their application. Currently, assessing such tradeoffs relies on intuition about how a certain pipeline will perform in a given genomic context. We present Stratomod, which addresses this problem using an interpretable machine-learning classifier to predict variant calling errors in a data-driven manner. We showed Stratomod can precisely quantify the likelihood of missing variants using Hifi or Illumina, and leveraged Stratomod’s interpretability to measure contributions from difficult-to-map and homopolymer regions for each respective outcome. Furthermore, we used Statomod to assess the likelihood of missing variants due to mismapping using linear vs. graph-based references, and identified the hard-to-map regions where graph-based methods excelled and by how much. For these we utilized our new benchmark based on the Q100 HG002 assembly, which contains previously-inaccessible difficult regions. Furthermore, Stratomod presents a new method of finding likely false negatives, which is an improvement over current pipelines which only filter false positives. We anticipate this being useful for performing precise risk-reward analyses when designing variant calling pipelines.